Anti-inflammatory drugs as anticancer agents

S Zappavigna, AM Cossu, A Grimaldi… - International journal of …, 2020 - mdpi.com
Inflammation is strictly associated with cancer and plays a key role in tumor development
and progression. Several epidemiological studies have demonstrated that inflammation can …

Targeting arachidonic acid pathway by natural products for cancer prevention and therapy

NS Yarla, A Bishayee, G Sethi, P Reddanna… - Seminars in cancer …, 2016 - Elsevier
Arachidonic acid (AA) pathway, a metabolic process, plays a key role in carcinogenesis.
Hence, AA pathway metabolic enzymes phospholipase A 2 s (PLA 2 s), cyclooxygenases …

ABC transporters in cancer: more than just drug efflux pumps

JI Fletcher, M Haber, MJ Henderson… - Nature Reviews Cancer, 2010 - nature.com
Multidrug transporter proteins are best known for their contributions to chemoresistance
through the efflux of anticancer drugs from cancer cells. However, a considerable body of …

Leukotrienes

M Peters-Golden… - New England Journal of …, 2007 - Mass Medical Soc
This review of leukotrienes, which are lipid mediators with a broad array of clinical effects,
and leukotriene receptors considers the biochemical and physiological aspects of these …

Cytosolic phospholipase A2 (cPLA2) IVA as a potential signature molecule in cigarette smoke condensate induced pathologies in alveolar epithelial lineages

SK Yadav, SK Sharma, A Farooque, G Kaushik… - Lipids in health and …, 2016 - Springer
Background Smoking is one of the leading causes of millions of deaths worldwide. During
cigarette smoking, most affected and highly exposed cells are the alveolar epithelium and …

Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk

AP Simopoulos - Experimental biology and medicine, 2010 - journals.sagepub.com
The tissue composition of polyunsaturated fatty acids is important to health and depends on
both dietary intake and metabolism controlled by genetic polymorphisms that should be …

Dietary fatty acids—The n-6n-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan

H Okuyama, T Kobayashi, S Watanabe - Progress in lipid research, 1996 - Elsevier
After the successful development of antibiotics and the improvement of nutritional and
hygienic conditions, mortalities from infectious diseases have decreased, and chronic …

Structure and ligand based drug design strategies in the development of novel 5-LOX inhibitors

P Aparoy, K Kumar Reddy… - Current medicinal …, 2012 - ingentaconnect.com
Lipoxygenases (LOXs) are non-heme iron containing dioxygenases involved in the
oxygenation of polyunsaturated fatty acids (PUFAs) such as arachidonic acid (AA) …

Lipoxygenase inhibitors as potential cancer chemopreventives

VE Steele, CA Holmes, ET Hawk, L Kopelovich… - … Biomarkers & Prevention, 1999 - AACR
Mounting evidence suggests that lipoxygenase (LO)-catalyzed products have a profound
influence on the development and progression of human cancers. Compared with normal …

Therapeutic options for 5-lipoxygenase inhibitors

O Werz, D Steinhilber - Pharmacology & therapeutics, 2006 - Elsevier
5-Lipoxygenase (5-LO) catalyzes the conversion of arachidonic acid (AA) into leukotriene
(LT) A4 and 5-hydroperoxyeicosatetraenoic acid. LTA4 can then be converted into LTB4 by …